These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 14523941)
1. Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments. Krauss U; Kratz F; Beck-Sickinger AG J Mol Recognit; 2003; 16(5):280-7. PubMed ID: 14523941 [TBL] [Abstract][Full Text] [Related]
2. A new daunomycin-peptide conjugate: synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro. Orbán E; Manea M; Marquadt A; Bánóczi Z; Csík G; Fellinger E; Bosze S; Hudecz F Bioconjug Chem; 2011 Oct; 22(10):2154-65. PubMed ID: 21950465 [TBL] [Abstract][Full Text] [Related]
3. Calcitonin-derived peptide carriers: mechanisms and application. Rennert R; Neundorf I; Beck-Sickinger AG Adv Drug Deliv Rev; 2008 Mar; 60(4-5):485-98. PubMed ID: 18160173 [TBL] [Abstract][Full Text] [Related]
4. Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. Machova Z; Mühle C; Krauss U; Tréhin R; Koch A; Merkle HP; Beck-Sickinger AG Chembiochem; 2002 Jul; 3(7):672-7. PubMed ID: 12325002 [TBL] [Abstract][Full Text] [Related]
5. Novel peptide conjugates for tumor-specific chemotherapy. Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056 [TBL] [Abstract][Full Text] [Related]
6. Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity. Rodrigues PC; Roth T; Fiebig HH; Unger C; Mülhaupt R; Kratz F Bioorg Med Chem; 2006 Jun; 14(12):4110-7. PubMed ID: 16546396 [TBL] [Abstract][Full Text] [Related]
7. New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells. Miklán Z; Orbán E; Csík G; Schlosser G; Magyar A; Hudecz F Biopolymers; 2009; 92(6):489-501. PubMed ID: 19521976 [TBL] [Abstract][Full Text] [Related]
8. Anthracycline-GnRH derivative bioconjugates with different linkages: synthesis, in vitro drug release and cytostatic effect. Schlage P; Mezo G; Orbán E; Bosze S; Manea M J Control Release; 2011 Dec; 156(2):170-8. PubMed ID: 21864594 [TBL] [Abstract][Full Text] [Related]
9. In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites. Orbán E; Mezo G; Schlage P; Csík G; Kulić Z; Ansorge P; Fellinger E; Möller HM; Manea M Amino Acids; 2011 Jul; 41(2):469-83. PubMed ID: 20953647 [TBL] [Abstract][Full Text] [Related]
10. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells. Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166 [TBL] [Abstract][Full Text] [Related]
11. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression. van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459 [TBL] [Abstract][Full Text] [Related]
12. Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR. Wagner K; Beck-Sickinger AG; Huster D Biochemistry; 2004 Oct; 43(39):12459-68. PubMed ID: 15449935 [TBL] [Abstract][Full Text] [Related]
13. Calcitonin-derived carrier peptide plays a major role in the membrane localization of a peptide-cargo complex. Boichot S; Krauss U; Plénat T; Rennert R; Milhiet PE; Beck-Sickinger A; Le Grimellec C FEBS Lett; 2004 Jul; 569(1-3):346-50. PubMed ID: 15225660 [TBL] [Abstract][Full Text] [Related]
14. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847 [TBL] [Abstract][Full Text] [Related]
15. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells. Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and application of peptides as drug carriers. Rennert R; Neundorf I; Beck-Sickinger AG Methods Mol Biol; 2009; 535():389-403. PubMed ID: 19377983 [TBL] [Abstract][Full Text] [Related]
17. [Transportation of cytotoxic liposomes to malignant cells using a carbohydrate determinant]. Vodovozova EL; Khaĭdukov SV; Gaenko GP; Bondarchuk TN; Mikhalev II; Grechishnikova IV; Molotkovskiĭ IuG Bioorg Khim; 1998 Oct; 24(10):760-7. PubMed ID: 9929737 [TBL] [Abstract][Full Text] [Related]
18. Nanoerythrosomes, a new derivative of erythrocyte ghost: III. Is phagocytosis involved in the mechanism of action? Lejeune A; Poyet P; Gaudreault RC; Gicquaud C Anticancer Res; 1997; 17(5A):3599-603. PubMed ID: 9413209 [TBL] [Abstract][Full Text] [Related]
19. Nanoerythrosome, a new derivative of erythrocyte ghost: preparation and antineoplastic potential as drug carrier for daunorubicin. Lejeune A; Moorjani M; Gicquaud C; Lacroix J; Poyet P; Gaudreault R Anticancer Res; 1994; 14(3A):915-9. PubMed ID: 8074493 [TBL] [Abstract][Full Text] [Related]
20. Nanoerythrosomes, a new derivative of erythrocyte ghost II: identification of the mechanism of action. Moorjani M; Lejeune A; Gicquaud C; Lacroix J; Poyet P; Gaudreault RC Anticancer Res; 1996; 16(5A):2831-6. PubMed ID: 8917393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]